Risk Scores for Transcatheter Tricuspid Interventions | JACC: CV Interventions

Frequency and Outcomes of Acute Hemodynamic Instability Following TTVR | JACC: CV Interventions

Cardiovascular Adverse Events Associated with Bispecific TCE Therapy | JACC: CardioOncology

Why Lowering LDL Below 55 Matters for ASCVD Patients | Asia Pulse

Rethinking Long-Term Beta‑Blocker Use After MI | Asia Pulse

Clopidogrel vs Aspirin—10-Year Real-World Results | Asia Pulse

Chagas Cardiomyopathy — Epidemiology Through Modern Clinical Trials | JACC Baran

Behind The Science: Social Risk and Mortality in Veterans With Cardiovascular Disease | JACC

Ethnicity, Race and Cardiovascular Risk | Asia Pulse

Real-Time IVUS Guided (RTIG) Stenting | Asia Pulse

ACC.26 Wrap Up | JACC

Panel Discussion: Social Drivers of Health | ACC.26 | JACC

Panel Discussion: Artificial Intelligence | ACC.26 | JACC

Quick Takes: CORALreef | ACC.26 | JACC

Quick Takes: DKCRUSH VIII (LBCT VII) | ACC.26 | JACC

Quick Takes: KARDINAL (LBCT II) | ACC.26 | JACC

Quick Takes: ORBITA-CTO (LBCT III) | ACC.26 | JACC

Dinesh Kalra Introduces His Vision as Incoming Editor-in-Chief | ACC.26 | JACC: Advances

Japanese Circulation Society 2026 Special — JACC at #26JCS | JACC Baran

ACC Anywhere TV From ACC.26 | Day 3 Daily Wrap Up

ACC26 Cardiology Hour | What should change in your practice after ACC 2026?

March 31, 2026: Global Cardiovascular Insights & Breakthroughs from China | JACC This Week

ACC Anywhere TV From ACC.26 | Day 2 Daily Wrap Up

ACC Anywhere TV From ACC.26 | Day 2 Daily Wrap Up

Behind The Science: Midventricular Obstruction in HCM: An Overlooked High‑Risk Phenotype | JACC

ACC Anywhere TV From ACC.26 | Day 1 Daily Wrap

ACC Anywhere TV From ACC.26 | Quick Takes: STEMI Door to Unload (LBCT I)

Mild PVR in TAVR — A Small Leak, Long-Term Impact | JACC Baran

March 24, 2026: Cardiometabolic Health, COVID Impact & Prevention Science | JACC This Week

Mechanical Debulking in Calcified Arteries: ROLLING STONE Study | JACC: CV Interventions

SJL Mid-Career Women’s Leadership Institute Finding Your “Next” | Dr. Christopher Kramer

Underrepresentation of Africa in RCTs | JACC

JACC Stats: Uncover the Insights Behind the Numbers | JACC Journal Club

March 17, 2026: Heart Failure, Chagas Research & AI in Cardiology

LDH in HFrEF — A Common Test, A Hidden Signal | JACC Baran

ACC International Conferences 2026

Designing Next-Gen Cardiometabolic Outcome Trials | JACC

JACC at CRT: Evolut and Beyond | JACC

JACC at CRT: Digital Health and AI | JACC

NCD Academy: Fighting NCDs Through Free Global Education

Current Landscape of Cardio-Oncology in China | JACC: Asia Pulse

Behind The Science Interview: JACC Stats and JACC Data Reports | JACC

Behind The Science Interview | JACC Data Reports

March 10, 2026: Inside JACC Stats: The State of CV Health in Focus | JACC this Week

TAVR and HFrEF — Are We Fully Applying GDMT? | JACC Baran

Tocilizumab and Low-Dose Dobutamine in in Acute MI | JACC

ACC.26 | Button-Up in Blue With Your ACC Family!

ACC.26 | Hands-On & Personalized Skill-Building

ACC.26 | Immerse Yourself in ACC.26's Most Interactive Sessions

ACC.26 | Collaboration Comes Alive in New Orleans

ACC.26 | Bold Breakthroughs: Late-Breaking Clinical Trials Revealed

ACC.26 | Crack the Escape Room Code

Experience New Orleans at ACC.26 | Let the Good Times Roll

March 3, 2026: Hypertrophic Cardiomyopathy in Focus

TR and AFib After M-TEER: A Risk Interaction to Watch | JACC Baran

Cancer Therapy Decisions: When to Continue, Pause or Stop? CardioOncology Insights | JACC:Asia Pulse

A Surgeon's Perspective | ACHD Guideline | JACC

Management of ACHD in Low Resource Settings | ACHD Guideline | JACC

The 2025 ACHD Guideline From the Early Career Perspective | ACHD Guideline | JACC

Behind The Science: Screening Young Individuals for SCD | JACC